CYBIN INC. · CYBN · 6-K · Filed
CEO Michael Halstead to Participate in Cantor Global Healthcare Conference Fireside Chat
CYBN
6-K
Other filings
Source: SEC EDGAR, accession 0001833141-26-000070
What did CYBIN INC. announce?
Helus Pharma CEO Michael Halstead will participate in a fireside chat at the Cantor Global Healthcare Conference on September 11, 2026.
Key details
- CEO Michael Halstead will speak at 8:00 a.m. EDT.
- The fireside chat will be webcast live and a replay will be available on the company's investor relations website.
Why it matters
This 6-K reports a corporate disclosure at CYBIN INC.. The likely share-price reaction reads as neutral.
Neutral